The proportion of the effect of BMI on MS, mediated by IL-6 signaling was estimated by dividing the indirect effect by the total effect of BMI on MS and corresponded to 43% (95% CI = 25%-54%). The gene discussed is IL6; the disease is myeloid sarcoma.